These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21766673)

  • 1. [Biguanides].
    Takahashi T; Odawara M
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():632-5. PubMed ID: 21766673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biguanides].
    Suzuki T; Miwa T; Notoya Y; Odawara M
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():627-32. PubMed ID: 17458294
    [No Abstract]   [Full Text] [Related]  

  • 3. [The biguanides].
    Taurand P
    Soins; 1987 Dec; (507):I-II. PubMed ID: 3438744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of biguanides on the indicators of thrombelastography and the level of lactic acid in diabetes mellitus].
    Blagosklonnaia IaV; Krasil'nikova EI; Zaĭed N; Babenko AIu
    Sov Med; 1990; (12):17-20. PubMed ID: 2097752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrates in the metabolic syndrome and in diabetes.
    Steiner G
    Endocrinol Metab Clin North Am; 2004 Sep; 33(3):545-55, vi-vii. PubMed ID: 15262296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biguanides in oral antidiabetic therapy: indications and limitations].
    Gregorio F; Filipponi P
    Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
    [No Abstract]   [Full Text] [Related]  

  • 9. Biguanides enhance glucose utilization and insulin action in peripheral tissues: an old finding from the sixties of the last century.
    Schatz H
    Horm Metab Res; 2006 Oct; 38(10):690. PubMed ID: 17075781
    [No Abstract]   [Full Text] [Related]  

  • 10. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
    Naruszewicz M
    Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thiazolidine derivatives].
    Hosoda K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():636-40. PubMed ID: 21766674
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biguanides in diabetes therapy. New aspects with special regard to the metabolic syndrome. Satellite symposium of the 2nd German Physicians' Conference. Dresden, 15 June 1991].
    Internist (Berl); 1991; 32(8 Suppl):1-12. PubMed ID: 1682287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term biguanide treatment in the natural evolution of NIDDM].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1996; ():273-88. PubMed ID: 8965430
    [No Abstract]   [Full Text] [Related]  

  • 14. Nutraceuticals in diabetes and metabolic syndrome.
    Davì G; Santilli F; Patrono C
    Cardiovasc Ther; 2010 Aug; 28(4):216-26. PubMed ID: 20633024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic approach to choose anti-diabetic drugs].
    Hirukawa H; Kaku K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():626-31. PubMed ID: 21766672
    [No Abstract]   [Full Text] [Related]  

  • 16. [What is new about diabetes mellitus, type 2?].
    Hügl SR; Palitzsch KD
    Krankenpfl J; 1999 Jun; 37(6):223-5. PubMed ID: 10524088
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alpha-Glucosidase inhibitors].
    Horikawa Y; Takeda J
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():641-4. PubMed ID: 21766675
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circadian profiles of lactic and pyruvic acid in diabetic patients treated with biguanides and sulfonylureas].
    Cheli V; Buzzo P; Melga P; Accoto S; Prando R
    Clin Ter; 1986 Aug; 118(4):269-75. PubMed ID: 3757467
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic utility of biguanides in the treatment of NIDDM].
    Fujimoto S
    Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.